Dr. Arthur M. Feldman | Medicinal Plants | Best Researcher Award
Lewis Katz School of Medicine at Temple University | United States
Author Profile
šArthur M. Feldman, MD, PhD: A Legacy of Excellence in Cardiology
šĀ EARLY ACADEMIC PURSUITS
Arthur M. Feldman, MD, PhD, embarked on his illustrious academic journey with a foundation in biology at Gettysburg College, where he earned a Bachelor of Arts in 1970. His pursuit of scientific excellence continued with a Masterās degree in Zoology (1973) and a Ph.D. in Physiology (1974) from the University of Maryland, College Park. Driven by a passion for understanding human physiology, he later achieved his MD from LSU School of Medicine in Shreveport in 1981, setting the stage for his impactful career in medicine.
š§ŖĀ PROFESSIONAL ENDEAVORS
Dr. Feldmanās career spans decades of distinguished service in academia, research, and clinical practice. Beginning as a Graduate Teaching Assistant at the University of Maryland, he rose through the ranks, holding prestigious positions such as Director of Heart Failure Research at Johns Hopkins and Chief of the Division of Cardiology at the University of Pittsburgh. His leadership extended to serving as Executive Dean at Temple Universityās School of Medicine and as the Laura H. Carnell Professor of Medicine. He also demonstrated entrepreneurial acumen by founding companies like Cardiokine, Inc., and Renovacor, Inc., contributing to advancements in cardiac care.
š¬ CONTRIBUTIONS AND RESEARCH FOCUS ON MEDICINAL PLANTS
Dr. Feldmanās research has profoundly shaped the understanding of heart failure, particularly in receptor-G protein signaling and matrix metalloproteinases. His innovative studies on G protein function in heart failure illuminated pathways for therapeutic interventions, while his work on metalloproteinases offered groundbreaking insights into cardiac remodeling. With over 400 manuscripts, 50 textbook chapters, and four books to his name, his scholarly contributions have earned him an H-index of 93 and more than 86,000 citations.
šĀ IMPACT AND INFLUENCE
As a pioneer in cardiology, Dr. Feldmanās influence extends beyond research. He has trained countless professionals, contributed to seminal guidelines on heart failure management, and played leadership roles in organizations like the Heart Failure Society of America and the American Heart Association. His editorial work for journals like Clinical and Translational Science has further solidified his standing as a thought leader.
šĀ ACADEMIC CITATIONS AND PUBLICATIONS
Dr. Feldmanās academic output is monumental, with key publications that have advanced the fields of heart failure and cardiac physiology. Notable works include studies on adrenergic signaling in failing hearts and the role of metalloproteinases in cardiac remodeling. These publications have shaped clinical practices and fostered new research directions.
š Ā HONORS & AWARDS
Dr. Feldmanās contributions have been recognized with numerous accolades:
- Lewis Gottlieb Scholar Award (1981)
- Distinguished Alumnus Award, Gettysburg College (1995)
- Lifetime Achievement Award, Heart Failure Society of America (2013)
- Distinguished Scientist Award, American College of Cardiology (2019)
- Senior Member, National Academy of Inventors (2023)
His consistent inclusion in āBest Doctors in Americaā reflects his enduring impact on the field.
šĀ LEGACY AND FUTURE CONTRIBUTIONS
As Dr. Feldman continues to contribute to the field through mentorship, research, and innovation, his legacy serves as an inspiration to future generations. His pioneering efforts in cardiology ensure a lasting impact on medical science and patient care.
š Ā FINAL NOTE
Dr. Feldmanās career exemplifies the fusion of academic rigor, clinical expertise, and innovative thinking. His work has not only advanced medical knowledge but also improved the lives of countless patients.
šĀ NOTABLE PUBLICATIONSĀ
The Role of BAG3 Protein Interactions in Cardiomyopathies
- Authors: Qu, H.-Q., Wang, J.-F., Rosa-Campos, A., Hakonarson, H., Feldman, A.M.
- Journal: International Journal of Molecular Sciences
- Year: 2024
Rare variants in cardiomyopathy genes predispose to cardiac injury in severe COVID-19 patients of African or Hispanic ancestry
- Authors: Qu, H.-Q., Delfiner, M.S., Gangireddy, C., Hakonarson, H., Feldman, A.M.
- Journal: Journal of Molecular Medicine
- Year: 2024
Dysregulated Autophagy and Sarcomere Dysfunction in Patients With Heart Failure With Co-Occurrence of P63A and P380S BAG3 Variants
- Authors: Martin, T.G., Pak, H., Gerhard, G.S., Feldman, A.M., Kirk, J.A.
- Journal: Journal of the American Heart Association
- Year: 2023
Bag3 Regulates Mitochondrial Function and the Inflammasome Through Canonical and Noncanonical Pathways in the Heart
- Authors: Wang, J., Tomar, D., Martin, T.G., Kirk, J.A., Feldman, A.M.
- Journal: JACC: Basic to Translational Science
- Year: 2023
Precision Medicine: Solving the Mystery of Myocarditis in the Aftermath of SARS-CoV-2
- Authors: Feldman, A.M., Kasper, E.K., Qu, H.-Q.
- Journal: JACC: Heart Failure
- Year: 2023